Inflated insulin costs lead to ‘death or debt dilemma’ in the US April 29, 2020 Kimberly Pharris, Share This StoryFacebookTwitteremailPrintLinkedinReddit (CNN) — An underground exchange for critical insulin and other medical supplies has emerged in the US as prices for type-1 diabetes treatments have skyrocketed in recent years.